eMedevents

Activity Objectives:

Current Challenges and New Opportunities in Hematopoietic Stem Cell Transplant is Course organized by i3 Health and will be held from May 31 - Dec 31, 2019.

Target Audience:
Hematology/oncology physicians, oncology advanced practitioners, oncology nurses, and other health care professionals involved in the treatment of patients eligible for HSCT.

CreditS:
1.0 AMA PRA Category 1 Credit ™
1.0 contact hour

Description:
Hematopoietic stem cell transplant is a potentially curative therapy for patients with hematologic malignancies. There are 2 primary types of HSCT: autologous, where the cells are taken from the patient, and allogeneic, where the cells come from a matched sibling donor or an unrelated donor. Advances in HSCT include the introduction of reduced-intensity conditioning regimens that allow transplant in older patients and alternative graft sources that afford a donor for nearly all patients who require a transplant. Despite these advances, studies continue to show that the use of HSCT remains suboptimal, placing many patients at increased risk for poor survival outcomes.

Objectives:
Upon completion of this activity, participants should be able to:
• Assess the susceptibility of hematologic malignancies to the graft-versus-leukemia effects of HSCT
• Evaluate emerging data on conditioning and consolidation/maintenance therapies that can optimize HSCT outcomes
• Apply strategies to manage transplant-related complications so that patients may achieve their goals of cancer therapy.

Intended Audience

Surgical Oncology, Haematology

Activity Payment Details

Activity Fee : Free

Rate this CME (Min 1 - Max 5)

Duration:
Fee and expenses:
CME credits:
Program contents:
Networking:
Write Your Review

Reviews Given by Professionals

No Reviews available. Be the first to write a review.

Privacy Policy

Read eMedEvents Privacy Policy

Organizer(s)

Help

+1 973-928-8085